Follow
Lambert Potin
Lambert Potin
Ph.D. in Biotechnology and Bioengineering
Verified email at alumni.epfl.ch
Title
Cited by
Cited by
Year
Lymph node stromal cells acquire peptide–MHCII complexes from dendritic cells and induce antigen-specific CD4+ T cell tolerance
J Dubrot, FV Duraes, L Potin, F Capotosti, D Brighouse, T Suter, ...
Journal of Experimental Medicine 211 (6), 1153-1166, 2014
2532014
Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma
M Fankhauser, MAS Broggi, L Potin, N Bordry, L Jeanbart, AW Lund, ...
Science Translational Medicine 9 (407), eaal4712, 2017
2222017
Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours
A Mansurov, J Ishihara, P Hosseinchi, L Potin, TM Marchell, A Ishihara, ...
Nature biomedical engineering 4 (5), 531-543, 2020
1662020
Targeted antibody and cytokine cancer immunotherapies through collagen affinity
J Ishihara, A Ishihara, K Sasaki, SSY Lee, JM Williford, M Yasui, H Abe, ...
Science Translational Medicine 11 (487), eaau3259, 2019
1622019
Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events
J Ishihara, K Fukunaga, A Ishihara, HM Larsson, L Potin, P Hosseinchi, ...
Science Translational Medicine 9 (415), eaan0401, 2017
1602017
Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy
JM Williford, J Ishihara, A Ishihara, A Mansurov, P Hosseinchi, ...
Science Advances 5 (12), eaay1357, 2019
1132019
Tumor-associated factors are enriched in lymphatic exudate compared to plasma in metastatic melanoma patients
MAS Broggi, L Maillat, CC Clement, N Bordry, P Corthésy, A Auger, ...
Journal of Experimental Medicine 216 (5), 1091-1107, 2019
1122019
Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges
K Maisel, MS Sasso, L Potin, MA Swartz
Advanced Drug Delivery Reviews 114, 43-59, 2017
1062017
Improving Efficacy and Safety of Agonistic Anti-CD40 Antibody Through Extracellular Matrix Affinity
J Ishihara, A Ishihara, L Potin, P Hosseinchi, K Fukunaga, M Damo, ...
Molecular cancer therapeutics 17 (11), 2399-2411, 2018
412018
The number of Toll-like receptor 9-agonist motifs in the adenovirus genome correlates with induction of dendritic cell maturation by adenovirus immune complexes
M Perreau, HC Welles, C Pellaton, B Gjoksi, L Potin, R Martin, A Harari, ...
Journal of virology 86 (11), 6279-6285, 2012
282012
Pro-lymphangiogenic VEGFR-3 signaling modulates memory T cell responses in allergic airway inflammation
K Maisel, CL Hrusch, JEG Medellin, L Potin, DB Chapel, H Nurmi, ...
Mucosal immunology 14 (1), 144-151, 2021
132021
Antigen presentation via MHC class II by lymphatic endothelial cells dampens CD4+ T cell response (IRC7P. 436)
L Potin, L Maillat, J Dubrot, F Duraes, S Hugues, M Swartz
The Journal of Immunology 194 (1_Supplement), 128.17-128.17, 2015
22015
Lymphatic vessels regulate exosome trafficking from tumors
L Maillat, L Potin, WW Kilarski, MA Swartz
Cancer Research 79 (13_Supplement), 4520-4520, 2019
12019
TGF-β Signaling Prevents MHC Class II–Expressing Lymphatic Endothelial Cells from Reactivating Human Allogenic Memory CD4+ T Cells
R Mezyk-Kopec, L Potin, JE Gomez Medellin, CM Salles, MA Swartz
The Journal of Immunology, 2023
2023
Method for treating melanoma using lymphangiogenesis inducers and a melanoma-specific antigen
MA Swartz, JA Hubbell, S Yu, E Vokali, M Fankhauser, S Hirosue, ...
US Patent 10,980,877, 2021
2021
Abstract B97: The immunomodulatory roles of tumor-associated lymphatics in triple-negative breast cancer
P Hosseinchi, L Potin, A Mansurov, L Maillat, JA Hubbell, MA Swartz
Cancer Immunology Research 8 (3_Supplement), B97-B97, 2020
2020
Collagen affinity improves safety and efficacy of antibody and cytokine cancer immunotherapies
J Ishihara, A Ishihara, A Mansurov, K Sasaki, SS Lee, JM Williford, L Potin, ...
Cancer Research 79 (13_Supplement), 1553-1553, 2019
2019
Abstract IA07: Using matrix protein affinity to modulate the tumor microenvironment
J Ishihara, A Ishihara, K Saskai, SSY Lee, M Yasui, H Abe, L Potin, ...
Cancer Immunology Research 7 (2_Supplement), IA07-IA07, 2019
2019
Inducing therapeutic lymphangiogenesis for potentiating cancer immunotherapy in melanoma
L Potin, L Maillat, PS Briquez, JA Hubbell, MA Swartz
Cancer Research 78 (13_Supplement), 1750-1750, 2018
2018
13 Exploring mechanisms of tumour lymphangiogenesis to potentiate immunotherapies in melanoma
L Potin, L Maillat, PS Briquez, M Fankhauser, JA Hubbell, MA Swartz
ESMO Open 3, A6, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–20